Drug Type Small molecule drug |
Synonyms 1-(p-tert-Butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine, Buclizine hydrochloride (USAN), NSC-25141 + [4] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date United States (08 Apr 1957), |
Regulation- |
Molecular FormulaC28H34Cl2N2 |
InChIKeyBFUBEWDYLSDZEV-UHFFFAOYSA-N |
CAS Registry129-74-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02089 | Buclizine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Dizziness | United States | 08 Apr 1957 | |
Motion Sickness | United States | 08 Apr 1957 | |
Nausea | United States | 08 Apr 1957 | |
Vertigo | United States | 08 Apr 1957 | |
Vomiting | United States | 08 Apr 1957 |